DRONTAL ALLWORMER - SM DOGS PUPPIES

Main information

  • Trade name:
  • DRONTAL ALLWORMER FOR SMALL DOGS & PUPPIES
  • Pharmaceutical form:
  • ORAL TABLET
  • Units in package:
  • 50Tab
  • Class:
  • Veterinary Medicine
  • Medicine domain:
  • Animals
  • Medicine type:
  • Allopathic drug
  • Manufactured by:
  • BAYER AUSTRALIA

Documents

Localization

  • Available in:
  • DRONTAL ALLWORMER FOR SMALL DOGS & PUPPIES
    Australia
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • DOG | DOG - LACTATING | DOG - PREGNANT | DOG - PUPPY | BITCH | CASTRATE | LACTATING DOG | PREGNANT DOG | PUPPY
  • Therapeutic area:
  • anthelmintic
  • Therapeutic indications:
  • GIARDIA SPP. | HOOKWORM | HOOKWORM - ANCYLOSTOMA CEYLANICUM | HYDATID TAPEWORM | ROUNDWORM - TOXASCARIS LEONINA | ROUNDWORM - TOXOCARA CANIS | TAPEWORM | TAPEWORM - DIPYLIDIUM CANINUM | TAPEWORM - TAENIA SPP. | WHIPWORM - TRICHURIS VULPIS | ANCYLOSTOMA BRAZILIENSE | ANCYLOSTOMA CANINUM | ASCARID | DIPYLIDIUM CANINUM | HUMAN INTESTINAL ROUNDWORM | TAENIA HYDATIGENA | TAENIA OVIS | TAENIA PISIFORMIS | TAENIA SPP. | UNCINARIA STENOCEPHALA
  • Product summary:
  • For the control of all gastrointestinal worms: roundworm, hookworm, whipworm and tapeworm in dogs, puppies, pregnant and lactating bitches, and to control the shedding of oocysts of the protozoan Giardia sp in dogs.TO BE USED BY, OR UNDER THE DIRECTION OF, A REGISTERED VETERINARY SURGEON ONLY.

Other information

Status

  • Source:
  • Australian Pesticides and Veterinary Medicines Authority (APVMA)
  • Authorization status:
  • Registered and available
  • Authorization number:
  • 35825/0210
  • Authorization date:
  • 25-03-2010
  • Last update:
  • 15-06-2017

Patient Information leaflet: composition, indications, side effects, dosage, interactions, adverse reactions, pregnancy, lactation

Drontal

Allwormer

®

®

5 0 TA B L E T S

FOR SMALL DOGS

AND PUPPIES

Drontal

Allwormer

®

®

FOR SMALL DOGS

AND PUPPIES

Drontal

Allwormer

®

®

FOR SMALL DOGS

AND PUPPIES

Drontal

Allwormer

®

®

FOR SMALL DOGS

AND PUPPIES

FOR ANIMAL TREATMENT ONLY

For the control of all gastrointestinal

worms: roundworm, hookworm,

whipworm and tapeworm in dogs,

puppies, pregnant and lactating bitches,

and to control the shedding of oocysts

of the protozoan Giardia sp. in dogs.

For the control of all gastrointestinal

worms: roundworm, hookworm,

whipworm and tapeworm in dogs,

puppies, pregnant and lactating bitches,

and to control the shedding of oocysts

of the protozoan Giardia sp. in dogs.

Each tablet contains

15 mg PRAZIQUANTEL

14.9 mg PYRANTEL as PYRANTEL EMBONATE

75 mg FEBANTEL

TO BE USED BY, OR UNDER THE DIRECTION OF,

A REGISTERED VETERINARY SURGEON ONLY.

DRONTAL is recommended for the control of all gastrointestinal

worms in dogs including:

Roundworm

Toxocara canis, Toxascaris leonina.

Hookworm

Ancylostoma caninum, Ancylostoma braziliense

(This hookworm is usually restricted to tropical

areas in Australia), Ancylostoma ceylanicum,

Uncinaria stenocephala.

Whipworm

Trichuris vulpis.

Tapeworm

Echinococcus granulosus (hydatid tapeworm),

Dipylidium caninum (common fl ea tapeworm),

Taenia spp., Taenia ovis, T. pisiformis, T.

hydatigena.

and to control the shedding of oocysts of the protozoan Giardia

sp. in dogs.

Does not control heartworm (Dirofi laria immitis).

READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT.

DIRECTIONS FOR USE

Dosage: 1 tablet per 3kg bodyweight. (Administer this dose

once for worms, and for 3 consecutive days for Giardia). If worm

problems persist, consult a veterinarian.

Disposal: Dispose of empty container and packaging by wrapping

in paper and putting in garbage.

Warranty:

Bayer

Australia

Limited

(BAL)

warrants

that

this

product is of merchantable quality and fi t for it’s intended purpose

indicated on this label. Notwithstanding anything else contained

on this label, BAL’s liability is limited to replacing this product or

supplying equivalent product or paying the cost of replacing this

product, at its discretion.

STORE BELOW 30°C

(Room Temperature)

APVMA Approval No 48642/0609

BAYER AUSTRALIA LTD.

ACN 000 138 714

875 Pacifi c Highway PYMBLE NSW 2073

DRONTAL

, and DRONTAL ALLWORMER

are registered trademarks of Bayer AG,

Leverkusen, Germany.

DRONTAL

, and DRONTAL ALLWORMER

is manufactured in Germany.

1006389 06/09

35825_44557_50_Primary carton_MPL_V01

Date: 0609

Dimensions: 17cm x 19.5 cm

Scale: Approximately 91% when printed to A4

APPROVED

LABEL

Info

pest

Verified

Allwormer

Drontal

FOR ANIMAL TREATMENT ONLY

FOR SMALL DOGS AND

PUPPIES

Each tablet contains

15 mg PRAZIQUANTEL

14.9 mg PYRANTEL

as PYRANTEL

EMBONATE

75 mg FEBANTEL

5 0 T A B L E T S

APVMA Approval No 35825/0609

BAYER AUSTRALIA LTD.

ACN 000 138 714

875 Pacific Highway Pymble NSW 2073

DRONTAL , and DRONTAL ALLWORMER are

registered trademarks of Bayer AG, Leverkusen, Germany.

Batch

Expiry

MN 1007288 07/03

TO BE USED BY, OR UNDER THE DIRECTION OF,

A REGISTERED VETERINARY SURGEON ONLY

DRONTAL is recommended for the control of all gastrointestinal worms in

dogs including: Roundworm Hookworm Whipworm Tapeworm and to

control the shedding of oocysts of the protozoan Giardia sp. in dogs.

Does not control heartworm (Dirofilaria immitis)

READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT.

DIRECTIONS FOR USE:

Dosage: 1 tablet per 3kg bodyweight. (Administer this dose once for worms, and

for 3 consecutive days for Giardia) STORE BELOW 30ºC

(Room Temperature).

Ph: (02) 4351 1350 Fax: (02) 4351 1320

ARTWORK / PROOF APPROVAL

T H I S S I G N E D P R O O F M U S T B E R E T U R N E D T O PA C I F I C L A B E L S P R I O R T O P R I N T I N G

IS TRIM SIZE CORRECT

IS TEXT / COPY CORRECT

ARE COLOURS CORRECT

IS APN SIZE AND No. CORRECT

All care has been taken to produce this artwork but FINAL RESPONSIBILITY IS LEFT WITH YOU, our valued client. PLEASE CHECK CAREFULLY and sign this notice. Should

any alterations be required mark clearly and return promptly. PLEASE NOTE: AUTHORS CORRECTIONS AT CLIENTS EXPENSE. COST TO BE ADVISED FOR APPROVAL.

MAGENTA

CYAN

BLACK

O.K. to print:

Changes & Re-submit:

Date:

MAGENTA

BLACK

PANTONE 321

BLACK

F/O No

DATE

ART VERSION

22/7/09

17411

83 mm

PLEASE NOTE: ART COSTS INCLUDE 1ST AUTHORS CORRECTIONS.

SUBSEQUENT CHANGES WILL BE CHARGED AT OUR MINIMUM RATE.

26 mm

35825_44557_50_Immediate bottle label_MPL_V01

Date: 0609

Dimensions: 83mm x 26 mm

Scale: Approximately 100% when printed to A4

APPROVED

LABEL

It should be noted that the hydatid tapeworm poses a severe risk to

human health by transmission to humans from infected dogs.

HOOKWORMS & ROUNDWORMS

Dogs and Puppies: treat at 2, 4, 8 and 12 weeks and then every

month until six months of age; thereafter every 3 months or on

veterinary advice.

Pregnant Bitches: treat prior to mating, then 10 days before whelping

and at 2 and 4 weeks after whelping.

WHIPWORMS

Treat every 6 to 8 weeks after 3 months of age.

TAPEWORMS

Treat every 3 months except in a hydatid tapeworm area where every

6 weeks is recommended, or on veterinary advice. Dogs can become

reinfested with worms and treatment should be repeated. Read the

retreatment recommendations below or consult your veterinarian.

Dipylidium caninum tapeworms are transmitted by fleas. Control of this

tapeworm should include flea control measures in addition.

Worms, if present, may not appear in the droppings at all, or may not

appear for up to 48 hours after treatment.

GIARDIA

This protozoan parasite is found commonly in dogs and may be the

cause of diarrhoea, particularly in pups. It is more common amongst

dogs living in multi-dog households and kennels. Giardia also occurs

in humans and has historically been considered a potential zoonosis,

however

recent

studies

suggest

that

host-specific

species

exist. Control of Giardia is difficult because the oocysts are resistant

and long-lived in the environment. Diagnosis of suspected Giardia

infection should be confirmed by a veterinary surgeon. Some evidence

indicates that bathing and a move to a non-contaminated environment

in conjunction with treatment will improve overall control.

Compatibility

DRONTAL may be combined with other treatments, for example

heartworm prevention, flea or tick treatment.

Safety

DRONTAL may be given safely to all dogs including old animals,

young pups, working dogs and greyhounds. It may be given to

pregnant bitches but is only clinically indicated in the last 10 days

prior to whelping. Side Effects: Vomiting may be observed in a

small number of dogs after administration.

Note

Zipper worm (Spirometra erinacei) is a less common tapeworm.

If segments are seen in the droppings less than 2 weeks after

treatment they probably belong to this worm. When tapeworm

treatment

only

required,

this

case,

give

DRONCIT

Tapewormer for Dogs and Cats which is specifically for tapeworm

treatment.

Disposal

Dispose of empty container by wrapping with paper and putting in

the garbage.

RETREATMENT RECOMMENDATIONS

Worms often reinfest dogs so it is necessary to:

treat the dog itself,

(ii)

reduce environmental contamination by daily disposal

of droppings,

(iii)

remove tapeworm intermediate hosts eg. fleas.

continued...

Drontal  Allwormer 

FOR SMALL DOGS AND PUPPIES

Drontal  Allwormer 

FOR DOGS

Drontal  Allwormer 

FOR LARGE DOGS

FOR ANIMAL TREATMENT ONLY

®

®

®

®

®

®

Product

Praziquantel

Pyrantel

Febantel

(as Pyrantel embonate)

Drontal Allwormer for

15 mg

14.9

75 mg

Small Dogs and Puppies

Drontal Allwormer

50 mg

49.8 mg

250 mg

for Dogs

Drontal Allwormer for

175 mg

174.4 mg

875 mg

Large Dogs

Each tablet contains

TO bE USED bY, OR UNDER THE DIRECTION OF,

A REGISTERED VETERINARY SURGEON ONLY

DRONTAL

is recommended for the control of all gastrointestinal worms

in dogs including:

Roundworm

Toxocara canis, Toxascaris leonina.

Hookworm

Ancylostoma caninum, Ancylostoma braziliense

(This hookworm is usually restricted to tropical areas

in Australia), Ancylostoma ceylanicum, Uncinaria

stenocephala.

Whipworm

Trichuris vulpis.

Tapeworm

Echinococcus granulosus (hydatid tapeworm), Dipylidium

caninum (common flea tapeworm), Taenia spp., Taenia

ovis, T. pisiformis, T. hydatigena.

and to control the shedding of oocysts of the protozoan Giardia sp. in

dogs.

Does not control heartworm (Dirofilaria immitis)

DIRECTIONS FOR USE

DRONTAL is given as a single dose by mouth. Fasting prior to dosing

is NOT necessary. IT IS ESSENTIAL TO WEIGH DOGS BEFORE

TREATMENT. See Dosing Recommendations below.

If worm problems persist consult a veterinarian.

Dosage

Small dogs and puppies

(using Drontal Allwormer for Small Dogs and Puppies)

bodyweight

Tablets

500g - 1.5kg

1.6 - 3kg

3.1 - 6kg

6.1 - 9kg

Medium dogs (using Drontal Allwormer for Dogs)

Large dogs (using Drontal Allwormer for Large Dogs)

Worms - Administer the above dosage once.

Giardia - Administer the above dosage for three

consecutive days. DRONTAL should be used only in

proven cases of Giardia sp. infection.

HYDATID TAPEWORM

A single dose of DRONTAL is all that is required. However, this dose

should be repeated every 6 weeks to ensure that newly acquired

hydatid

tapeworms

expelled

before

reaching

maturity.

Dogs

should not be fed, or allowed to feed on, offal from any species.

Dogs in hydatid areas should be treated every 6 weeks. It is

important to ensure that the dog does not acquire offal in order to

break the life cycle of the hydatid tapeworm.

bodyweight

Tablets

20 - 35 kg

35.1 - 52 kg

52.1 - 70 kg

70.1 - 87 kg

Over 87 kg

bodyweight

Tablets

1.5 - 2.5 kg

2.6 - 5 kg

5.1 - 10 kg

Over 10 kg

1 tablet for every 10kg

bodyweight.

Round off doses to the

nearest 1/2 tablet above.

Treat at

2,4,8,12 weeks;

then 4,5,6

months of age.

Every 3 months.

Every 6 weeks in Hydatid

infested locations.

If whipworm is a problem

retreat every 6-8 weeks.

Prior to mating, 10-days

before whelping and

2 and 4 weeks after

whelping.

Follow the retreatment recommendations in the table below:

PUPPIES

ADULTS

PREGNANT/LACTATING

(over 6 months)

bITCHES

These

recommendations

general

nature.

specific

instances where infestation is particularly heavy or many dogs

are housed together, a veterinary surgeon should be consulted.

Flea tapeworms can reinfest dogs and begin producing segments

2-3 weeks after a treatment. If segments reappear before the next

DRONTAL treatment is due, either re-treat with DRONTAL or use

DRONCIT as an intermediate, tapeworm only, treatment.

Retreatment for Giardia depends on the circumstances and should

be guided by your veterinary surgeon. A single 3 day treatment may

be sufficient in single dog situations, but repeat treatments may be

necessary in kennels and shelters.

Storage: Store below 30°(Room Temperature)

Presentation and APVMA Approval Nos

Drontal Allwormer for Small Dogs & Puppies

50 tablets

35825/0210

Drontal Allwormer for Dogs

100 tablets

35822/0210

Drontal Allwormer for Large Dogs

70 tablets

35824/0210

Warranty: Bayer Australia Limited (BAL) warrants that this product is

of merchantable quality and fit for it's intended purpose indicated on

this label. Notwithstanding anything else contained on this label, BAL's

liability is limited to replacing this product or supplying equivalent product

or paying the cost of replacing this product, at its discretion.

bAYER AUSTRALIA LTD.

ACN 000 138 714

875 Pacific Highway, Pymble NSW 2073

DRONTAL

, DRONTAL ALLWORMER

and DRONCIT

are registered

trademarks of Bayer AG, Leverkusen, Germany.

02/10

1007733

42773 Bayer Drontal Dog.indd 1-3

11/02/10 2:17 PM

35825,35824,35822_45912,49131,49120_50,100,70_Common leaflet_MPL_V01

Date: 0210

Dimensions: 207mm x 100mm

Scale: Approx. 100% when printed to A4

Info

pest

Verified

17-1-2019

Safety of cassia gum as a feed additive for cats and dogs based on a dossier submitted by Glycomer GmbH

Safety of cassia gum as a feed additive for cats and dogs based on a dossier submitted by Glycomer GmbH

Published on: Wed, 16 Jan 2019 The additive cassia gum consists mainly of high-molecular weight polysaccharides composed primarily of a linear chain of 1,4-b-D-mannopyranose units with 1,6-linked a-D-galactopyranose units. In 2014, the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) delivered an opinion on the safety and efficacy of cassia gum in cats and dogs. The Panel concluded, based on positive findings observed in a bacterial reverse mutation test with a semi-refined cassia...

Europe - EFSA - European Food Safety Authority EFSA Journal

15-1-2019

Voorstelling van Zaken “GOED SCHEIDEN” in Internationaal Theater Amsterdam

Voorstelling van Zaken “GOED SCHEIDEN” in Internationaal Theater Amsterdam

De komende Voorstelling van Zaken GOED SCHEIDEN vindt plaats op dinsdag 26 februari 2019 van 14.00-17.15 uur in Internationaal Theater Amsterdam (voorheen Stadsschouwburg Amsterdam). De voorstelling is bedoeld voor professionals betrokken bij scheidingen. Phaedra Werkhoven, journalist en ervaringsdeskundige, leidt de gesprekken op het toneel. Acteurs Gijs Scholten van Aschat, Jacob Derwig en Hannah van Lunteren spelen scènes die de scheidingsproblematiek op unieke wijze zullen laten zien. Scheiden is pij...

Netherlands - Ministerie van Volksgezondheid, Welzijn en Sport

21-12-2018

Avian influenza overview August – November 2018

Avian influenza overview August – November 2018

Published on: Thu, 20 Dec 2018 Between 16 August and 15 November 2018, 14 highly pathogenic avian influenza (HPAI) A(H5N8) outbreaks in poultry establishments in Bulgaria and seven HPAI A(H5N6) outbreaks, one in captive birds in Germany and six in wild birds in Denmark and the Netherlands were reported in the European Union (EU). No human infection due to HPAI A(H5N8) and A(H5N6) viruses have been reported in Europe so far. Seroconversion of people exposed during outbreaks in Russia has been reported in...

Europe - EFSA - European Food Safety Authority EFSA Journal

18-12-2018


eXtended EudraVigilance Medicinal Product Dictionary face-to-face training course (Amsterdam), BCN Amsterdam Arena, Atlas Arena Complex Amsterdam, The Netherlands, from 14/02/2019 to 15/02/2019

eXtended EudraVigilance Medicinal Product Dictionary face-to-face training course (Amsterdam), BCN Amsterdam Arena, Atlas Arena Complex Amsterdam, The Netherlands, from 14/02/2019 to 15/02/2019

eXtended EudraVigilance Medicinal Product Dictionary face-to-face training course (Amsterdam), BCN Amsterdam Arena, Atlas Arena Complex Amsterdam, The Netherlands, from 14/02/2019 to 15/02/2019

Europe - EMA - European Medicines Agency

15-12-2018

Annual Report of the Scientific Network on BSE‐TSE 2018

Annual Report of the Scientific Network on BSE‐TSE 2018

Published on: Fri, 14 Dec 2018 The EFSA Scientific Network on bovine spongiform encephalopathies and other transmissible spongiform encephalopathies (BSE‐TSE) held its 13th meeting on 15‐16 October 2018 in Parma. The meeting served as an opportunity to exchange scientific information on BSE‐TSE related issues among EU Member States, countries from the European Free Trade Association (EFTA), EFSA, the European Commission and ad hocparticipants. In this occasion, ad hoc representation included the World A...

Europe - EFSA - European Food Safety Authority Publications

13-11-2018

Oscor Inc. Issues Recall Product Expansion of TB – Temporary Bipolar Pacing Lead (Unshrouded 2 mm Pins Models)

Oscor Inc. Issues Recall Product Expansion of TB – Temporary Bipolar Pacing Lead (Unshrouded 2 mm Pins Models)

On September 26, 2018 Oscor notified customers of a recall for certain lots (Recall No. 1035166- 09/07/2018-01-R) of TB Unshrouded Bipolar Pacing Leads. As part of the recall correction activities, Oscor is retrieving any remaining inventory out in the field. The recall scope is being expanded to include expired inventory for devices distributed between December 21, 2011 to May 17, 2018. The recall expansion is to ensure proper disposition of expired units. The FDA has been notified and is aware Oscor In...

FDA - U.S. Food and Drug Administration

9-11-2018

Safety assessment of the substance Ln 1,4‐benzene dicarboxylic acid (with Ln = La, Eu, Gd, Tb) for use in food contact materials

Safety assessment of the substance Ln 1,4‐benzene dicarboxylic acid (with Ln = La, Eu, Gd, Tb) for use in food contact materials

Published on: Wed, 07 Nov 2018 00:00:00 +0100 The EFSA Panel on Food Contact Materials, Enzymes and Processing Aids (CEP Panel) assessed the safety of the additive Ln 1,4‐benzene dicarboxylic acid (with Ln = La, Eu, Gd, Tb) for use in food contact materials. It is a family of mixtures combining the four lanthanides lanthanum (La), europium (Eu), gadolinium (Gd) and/or terbium (Tb) in different proportions as their 1,4‐benzene dicarboxylate complexes, used as a taggant in plastics for authentication and ...

Europe - EFSA - European Food Safety Authority Publications

27-9-2018

Oscor Inc. Issues Recall of TB – Temporary Bipolar Pacing Lead (Unshrouded 2 mm Pins Models)

Oscor Inc. Issues Recall of TB – Temporary Bipolar Pacing Lead (Unshrouded 2 mm Pins Models)

During the use of some TB - Temporary Bipolar Pacing Leads, featuring the 2mm unshrouded connectors, the connector cap housing (see Picture 1, No. 2 Pin Cap and Cover) may slide and potentially expose the connection wire. In some instances, this may cause the wire to be more susceptible to loss of connectivity or breakage during movement of the cables causing interruption of the pacing system. The analysis of the returned devices attributed the failure to a design change of the cap housing of the pins. ...

FDA - U.S. Food and Drug Administration

26-9-2018

Technical Report on the notification of syrup from Sorghum bicolor (L.) Moench as a traditional food from a third country pursuant to Article 14 of Regulation (EU) 2015/2283

Technical Report on the notification of syrup from Sorghum bicolor (L.) Moench as a traditional food from a third country pursuant to Article 14 of Regulation (EU) 2015/2283

Published on: Tue, 25 Sep 2018 00:00:00 +0200 Abstract Following a notification from Sorghum Zrt., submitted to the European Commission under Article 14 of Regulation (EU) 2015/2283 to place on the market syrup from Sorghum bicolor (L.) Moench as a traditional food from a third country (TF), and in line with Article 15(2) of that Regulation, EFSA was asked by the European Commission whether there are duly reasoned safety objections to the placing on the market of the TF within the European Union. The ap...

Europe - EFSA - European Food Safety Authority Publications

29-8-2018

Risk to human and animal health related to the presence of 4,15‐diacetoxyscirpenol in food and feed

Risk to human and animal health related to the presence of 4,15‐diacetoxyscirpenol in food and feed

Published on: Thu, 16 Aug 2018 00:00:00 +0200 4,15‐Diacetoxyscirpenol (DAS) is a mycotoxin primarily produced by Fusarium fungi and occurring predominantly in cereal grains. As requested by the European Commission, the EFSA Panel on Contaminants in the Food Chain (CONTAM) assessed the risk of DAS to human and animal health related to its presence in food and feed. Very limited information was available on toxicity and on toxicokinetics in experimental and farm animals. Due to the limitations in the avai...

Europe - EFSA - European Food Safety Authority Publications

23-2-2018

Bella all Natural Issues Voluntary Nationwide Recall of Diet Capsules Labeled as Bella, Due to Presence of Sibutramine

Bella all Natural Issues Voluntary Nationwide Recall of Diet Capsules Labeled as Bella, Due to Presence of Sibutramine

Bella All Natural is voluntarily recalling its Diet Capsules labeled as Bella, Lot Number MFD:10.15.2017 EXP: 10.14.2019, to the consumer level.

FDA - U.S. Food and Drug Administration

3-1-2012

Danish Pharmacovigilance Update, 15 December 2011

Danish Pharmacovigilance Update, 15 December 2011

Among the topics covered in this issue of Danish Pharmacovigilance Update are: Atomoxetine (Strattera®) and the risk of increased blood pressure and heart rate, increased suspicion of risk of congenital malformations with the antiepileptic topiramate (Topimax® and others), and new recommendations for the antidepressant escitalopram.

Danish Medicines Agency

23-11-2018

.@US_FDA issues Class I Medical Device Recall, the most serious type of   recall: Oscor Recalls TB Temporary Bipolar Pacing Leads Due to  Connector Separation Causing Potential for Loss of Pacing. Find out  more:  https://go.usa.gov/xPHxF  #FDA #MedicalDe

.@US_FDA issues Class I Medical Device Recall, the most serious type of recall: Oscor Recalls TB Temporary Bipolar Pacing Leads Due to Connector Separation Causing Potential for Loss of Pacing. Find out more: https://go.usa.gov/xPHxF  #FDA #MedicalDe

. @US_FDA issues Class I Medical Device Recall, the most serious type of recall: Oscor Recalls TB Temporary Bipolar Pacing Leads Due to Connector Separation Causing Potential for Loss of Pacing. Find out more: https://go.usa.gov/xPHxF  #FDA #MedicalDevice pic.twitter.com/negJ6HU4x2

FDA - U.S. Food and Drug Administration

27-7-2018

EU/3/15/1473 (Celgene Europe B.V.)

EU/3/15/1473 (Celgene Europe B.V.)

EU/3/15/1473 (Active substance: Lenalidomide) - Transfer of orphan designation - Commission Decision (2018)5042 of Fri, 27 Jul 2018 European Medicines Agency (EMA) procedure number: EMA/OD/284/14/T/01

Europe -DG Health and Food Safety

27-6-2018

EU/3/15/1460 (Eisai GmbH)

EU/3/15/1460 (Eisai GmbH)

EU/3/15/1460 (Active substance: Lenvatinib) - Transfer of orphan designation - Commission Decision (2018)4080 of Wed, 27 Jun 2018 European Medicines Agency (EMA) procedure number: EMA/OD/287/14/T/01

Europe -DG Health and Food Safety

29-5-2018

EU/3/15/1453 (Roche Registration GmbH)

EU/3/15/1453 (Roche Registration GmbH)

EU/3/15/1453 (Active substance: Chimeric 2'-O-(2-methoxyethyl) modified oligonucleotide targeted to huntingtin RNA) - Transfer of orphan designation - Commission Decision (2018)3401 of Tue, 29 May 2018 European Medicines Agency (EMA) procedure number: EMA/OD/256/14/T/01

Europe -DG Health and Food Safety

21-5-2018

EU/3/07/522 (Best Regulatory Consulting Ltd)

EU/3/07/522 (Best Regulatory Consulting Ltd)

EU/3/07/522 (Active substance: (manganese, dichloro [(4aR, 13aR, 17aR, 21aR)-1, 2, 3, 4, 4a, 5, 6, 12, 13, 13a, 14, 15, 16, 17, 17a, 18, 19, 20, 21, 21a-eicosahydro-11, 7-nitrilo-7H-dibenzo[ b,h] [1,4,7,10] tetraazacycloheptadecine-?N5, ?N13, ?N18, ?N21, ?N22]-)) - Transfer of orphan designation - Commission Decision (2018)3136 of Mon, 21 May 2018 European Medicines Agency (EMA) procedure number: EMA/OD/089/07/T/01

Europe -DG Health and Food Safety